近日，国家企业信用信息公示系统显示，上海药明生基医药科技有限公司（以下简称“上海药明生基”）发生工商变更，注册资本由1亿元增至6亿元，增幅高达500%。与此同时，无锡生基医药科技有限公司（以下简称“无锡生基医药”）将其持有的上海药明生基100%股份转让给无锡药明康德新药开发股份有限公司（以下简称“药明康德”）。上海药明生基成立于2020年9月，法定代表人为张朝晖，经营范围涵盖企业管理、信息咨询及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.